Drugs / KI1106
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03482180 | May 2016 → May 2017 | hyperlipidemia | Kuhnil Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KI1106 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03482180 ↗ |